| Followers | 312 |
| Posts | 10714 |
| Boards Moderated | 16 |
| Alias Born | 02/24/2010 |
Tuesday, November 30, 2021 8:22:19 AM
$HEPA FDA consider crv431 a drug with excellent efficacy and safety profile to potentially treat Nash. A very good support from FDA to Hepion.
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM

